G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 109 filers reported holding G1 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $262,409 | +8.3% | 105,385 | +136.3% | 0.01% | -23.1% |
| Q4 2022 | $242,194 | -50.9% | 44,603 | +12.9% | 0.01% | -31.6% |
| Q3 2022 | $493,000 | +142.9% | 39,500 | -3.8% | 0.02% | +111.1% |
| Q2 2022 | $203,000 | +2.5% | 41,054 | +111.6% | 0.01% | -25.0% |
| Q4 2021 | $198,000 | -73.4% | 19,400 | -42.8% | 0.01% | -83.3% |
| Q2 2021 | $744,000 | +107.2% | 33,902 | +8.9% | 0.07% | 0.0% |
| Q3 2020 | $359,000 | – | 31,124 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |